Myeloid Toxicity of Cancer Treatment

  • Sandra Kurtin
  • Published 2012 in Journal of the advanced practitioner in oncology

Abstract

Myelotoxicity is one of the most common treatment-related adverse events for patients receiving systemic antineoplastic therapy or radiotherapy to bone marrow-producing regions. Myeloid cytopenias, including neutropenia, thrombocytopenia, and anemia, are the most common manifestations of treatment-related myelotoxicity and one of the most common reasons for… (More)

Topics

9 Figures and Tables

Cite this paper

@inproceedings{Kurtin2012MyeloidTO, title={Myeloid Toxicity of Cancer Treatment}, author={Sandra Kurtin}, booktitle={Journal of the advanced practitioner in oncology}, year={2012} }